No doubt that will be "commercially sensitive"
Printable View
This is one of my bigger holdings but I've reduced last week and this morning. I see this as extra risk on a company well priced for growth. I'll look at buying back once this is resolved, but why take the risk? Surely there is potential here for this to throw a spanner in the works? ResMed have litigated over patents previously and been successful and they have deep pockets.
1st half net profit guidance $76m up 23% / FY $165m up 15% - low end of earlier forecast due to high NZD. Also FPH to spend NZ$200m on building expansion in NZ and Mexico over next 4 to 5 years. Funded from existing facilities.
https://www.nzx.com/companies/FPH/announcements/287720
Thanks for posting IAK... I was at ASM yesterday... haven't had chance to comment yet... currently on the Sky Bus heading for Auckland Airport will comment further tonight when I have key board to work with.
Just received the contract note for the ones I sold, and see I received $10.1378 ps share .
There were buyers at $10.20 when I put them on the market.
Now I see the last sale was $9.90.
good opportunity to buy